Antimicrobial Resistance (AMR) Surveillance: Ten Years On

IF 8.3 1区医学 Q1 IMMUNOLOGY

Clinical Infectious Diseases Pub Date : 2026-10-18 DOI:10.1093/cid/ciag496

引用次数: 0

Abstract

Antimicrobial resistance threatens to reverse decades of medical progress, turning once-routine infections into life-threatening conditions and placing growing strain on health systems and economies worldwide. The urgency to act has never been greater: without decisive intervention, an estimated 39 million deaths could be attributable to AMR between 2025 and 2050 [1], while the global economy could be up to US$1.7 trillion smaller annually by mid-century [2].

查看原文本刊更多论文

抗生素耐药性（AMR）监测：十年来

抗微生物药物耐药性有可能逆转数十年的医学进步，将曾经的常规感染转变为危及生命的疾病，并对世界各地的卫生系统和经济造成越来越大的压力。采取行动的紧迫性从未如此之大：如果不采取果断干预措施，估计2025年至2050年期间将有3900万人死于抗生素耐药性，而到本世纪中叶，全球经济每年可能减少1.7万亿美元。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Infectious Diseases 医学-传染病学

CiteScore

25.00

自引率

2.50%

发文量

900

审稿时长

3 months

期刊介绍： Clinical Infectious Diseases (CID) is dedicated to publishing original research, reviews, guidelines, and perspectives with the potential to reshape clinical practice, providing clinicians with valuable insights for patient care. CID comprehensively addresses the clinical presentation, diagnosis, treatment, and prevention of a wide spectrum of infectious diseases. The journal places a high priority on the assessment of current and innovative treatments, microbiology, immunology, and policies, ensuring relevance to patient care in its commitment to advancing the field of infectious diseases.